| Dr Nadine Youssef, MD | |
|
750 Washington St, Box 311 / Department Of Emergency Medicine, Boston, MA 02111-1526 | |
| (617) 636-4723 | |
| Not Available |
| Full Name | Dr Nadine Youssef |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 20 Years |
| Location | 750 Washington St, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013177427 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 235098 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Tufts Medical Center | Boston, MA | Hospital |
| Metrowest Medical Center | Framingham, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Tufts Medical Center Ep Llc | 0446306716 | 13 |
| Emergency Physician Associates Of Massachusetts Pc | 4981069580 | 46 |
News Archive
Frost & Sullivan believes that the healthcare industry is undergoing a paradigm shift from "sickness care" to "wellness". Focused on the 5 Ps – Preventive, Pre-emptive, Personalized, Predictive and Personal Responsibility – the healthcare industry in Asia Pacific is expected to grow to US$349 billion by 2012.
Scientists in Sweden have innovated a method of treating blindness using embryonic stem cells to produce retinal cells.
Diabetes is a growing health problem. Giving antioxidants is recognised as one way of helping people with diabetes to control their blood sugar levels.
A team of cardiologists from the Montreal Heart Institute (MHI) specializing in cardiac arrhythmias has used for the very first time in Canada, a technology developed in Montreal to treat a patient with atrial fibrillation. Recently licenced by Health Canada, this sophisticated device is a balloon inserted by catheter that uses extreme cold to burn malfunctioning heart tissue.
Intercept Pharmaceuticals, Inc., today announced positive results from a 59 patient, placebo controlled, double-blind Phase II clinical trial of obeticholic acid given as monotherapy to patients with primary biliary cirrhosis.
› Verified 5 days ago
| Entity Name | Tufts Medical Center Ep Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609015262 PECOS PAC ID: 0446306716 Enrollment ID: O20090929000298 |
News Archive
Frost & Sullivan believes that the healthcare industry is undergoing a paradigm shift from "sickness care" to "wellness". Focused on the 5 Ps – Preventive, Pre-emptive, Personalized, Predictive and Personal Responsibility – the healthcare industry in Asia Pacific is expected to grow to US$349 billion by 2012.
Scientists in Sweden have innovated a method of treating blindness using embryonic stem cells to produce retinal cells.
Diabetes is a growing health problem. Giving antioxidants is recognised as one way of helping people with diabetes to control their blood sugar levels.
A team of cardiologists from the Montreal Heart Institute (MHI) specializing in cardiac arrhythmias has used for the very first time in Canada, a technology developed in Montreal to treat a patient with atrial fibrillation. Recently licenced by Health Canada, this sophisticated device is a balloon inserted by catheter that uses extreme cold to burn malfunctioning heart tissue.
Intercept Pharmaceuticals, Inc., today announced positive results from a 59 patient, placebo controlled, double-blind Phase II clinical trial of obeticholic acid given as monotherapy to patients with primary biliary cirrhosis.
› Verified 5 days ago
| Entity Name | Emergency Physician Associates Of Massachusetts Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730885252 PECOS PAC ID: 4981069580 Enrollment ID: O20230504001402 |
News Archive
Frost & Sullivan believes that the healthcare industry is undergoing a paradigm shift from "sickness care" to "wellness". Focused on the 5 Ps – Preventive, Pre-emptive, Personalized, Predictive and Personal Responsibility – the healthcare industry in Asia Pacific is expected to grow to US$349 billion by 2012.
Scientists in Sweden have innovated a method of treating blindness using embryonic stem cells to produce retinal cells.
Diabetes is a growing health problem. Giving antioxidants is recognised as one way of helping people with diabetes to control their blood sugar levels.
A team of cardiologists from the Montreal Heart Institute (MHI) specializing in cardiac arrhythmias has used for the very first time in Canada, a technology developed in Montreal to treat a patient with atrial fibrillation. Recently licenced by Health Canada, this sophisticated device is a balloon inserted by catheter that uses extreme cold to burn malfunctioning heart tissue.
Intercept Pharmaceuticals, Inc., today announced positive results from a 59 patient, placebo controlled, double-blind Phase II clinical trial of obeticholic acid given as monotherapy to patients with primary biliary cirrhosis.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nadine Youssef, MD 245 Williamson Dr, Somerset, MA 02726-3225 Ph: (508) 673-0855 | Dr Nadine Youssef, MD 750 Washington St, Box 311 / Department Of Emergency Medicine, Boston, MA 02111-1526 Ph: (617) 636-4723 |
News Archive
Frost & Sullivan believes that the healthcare industry is undergoing a paradigm shift from "sickness care" to "wellness". Focused on the 5 Ps – Preventive, Pre-emptive, Personalized, Predictive and Personal Responsibility – the healthcare industry in Asia Pacific is expected to grow to US$349 billion by 2012.
Scientists in Sweden have innovated a method of treating blindness using embryonic stem cells to produce retinal cells.
Diabetes is a growing health problem. Giving antioxidants is recognised as one way of helping people with diabetes to control their blood sugar levels.
A team of cardiologists from the Montreal Heart Institute (MHI) specializing in cardiac arrhythmias has used for the very first time in Canada, a technology developed in Montreal to treat a patient with atrial fibrillation. Recently licenced by Health Canada, this sophisticated device is a balloon inserted by catheter that uses extreme cold to burn malfunctioning heart tissue.
Intercept Pharmaceuticals, Inc., today announced positive results from a 59 patient, placebo controlled, double-blind Phase II clinical trial of obeticholic acid given as monotherapy to patients with primary biliary cirrhosis.
› Verified 5 days ago
Yeu-shin Cindy Chang, M.D., M.P.H. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Bwh Dept. Of Emergency Medicine, Boston, MA 02115 Phone: 617-732-8070 | |
Lorenzo Albala, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 55 Fruit St, Boston, MA 02114 Phone: 617-724-4068 | |
Dr. Jacob Ari Hurwitz, MD MPH Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 55 Fruit St, Boston, MA 02114 Phone: 617-724-4068 | |
Christopher Lites, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 330 Brookline Ave, Boston, MA 02215 Phone: 617-667-7000 | |
Aneesh T Narang, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1 Boston Medical Ctr Pl, Dowling 1 South, Boston, MA 02118 Phone: 617-414-5481 Fax: 617-414-7759 | |
Dr. Justin Thomas Pitman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 75 Francis St, Neville House - 236a, Boston, MA 02115 Phone: 617-732-8070 |